Abstract
Hypercholesterolemia in patients after renal transplantation composes a significant risk factor of cardio-vascular disease, it may also worsen graft survival. Statins are the most potent drugs to lower blood cholesterol. They also posses numerous pleiotropic abilities. The paper presents benefits of the use of statins in patients after renal transplantation, as well as the dangers related to the side effects of these drugs. It underlines that adequate use of statins is worth considering in patients after renal transplantation, taking into account not only their ability to lower cholesterol but also their additional properties positively influencing graft survival.
MeSH terms
-
Atorvastatin
-
Heptanoic Acids / adverse effects
-
Heptanoic Acids / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacokinetics
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypercholesterolemia / drug therapy
-
Hypercholesterolemia / etiology*
-
Kidney Transplantation*
-
Lovastatin / adverse effects
-
Lovastatin / therapeutic use
-
Postoperative Complications / drug therapy
-
Pravastatin / adverse effects
-
Pravastatin / therapeutic use
-
Pyrroles / adverse effects
-
Pyrroles / therapeutic use
-
Simvastatin / adverse effects
-
Simvastatin / therapeutic use
Substances
-
Heptanoic Acids
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Pyrroles
-
Lovastatin
-
Atorvastatin
-
Simvastatin
-
Pravastatin